Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amantadine VS Ritalin in the Treatment of ADHD
NCT01099059Phase 2Unknown
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2010
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of amantadine in attention deficit hyperactivity disorder (ADHD), sponsored by Tehran University of Medical Sciences. Status: unknown.
02
Drugs
amantadine
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01099059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01099059.